title: Donor administration of PAF antagonist (TCV-309) enhances lung preservation.
authors.affiliation: First Department of Surgery, Nagasaki University School of Medicine, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Ide
authors.forename: K
authors.initials: K
authors.lastname: Kawahara
authors.forename: T
authors.initials: T
authors.lastname: Takahashi
authors.forename: N
authors.initials: N
authors.lastname: Sasaki
authors.forename: H
authors.initials: H
authors.lastname: Shingu
authors.forename: T
authors.initials: T
authors.lastname: Nagayasu
authors.forename: S
authors.initials: S
authors.lastname: Yamamoto
authors.forename: T
authors.initials: T
authors.lastname: Tagawa
authors.forename: M
authors.initials: M
authors.lastname: Tomita
mesh_terms: D000818:Animals; D002245:Carbon Dioxide / Q000097:blood; D004285:Dogs; D007546:Isoquinolines / Q000494:pharmacology*; D008168:Lung / Q000187:drug effects; D016040:Lung Transplantation / Q000473:pathology / Q000502:physiology*; D009926:Organ Preservation / Q000379:methods*; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D009195:Peroxidase / Q000032:analysis; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D011651:Pulmonary Artery / Q000502:physiology; D011667:Pulmonary Veins / Q000502:physiology; D011726:Pyridinium Compounds / Q000494:pharmacology*; D015424:Reperfusion; D015427:Reperfusion Injury / Q000517:prevention & control*; D044005:Tetrahydroisoquinolines
chemical_list: D007546:Isoquinolines; D010972:Platelet Activating Factor; D011726:Pyridinium Compounds; D044005:Tetrahydroisoquinolines; D002245:Carbon Dioxide; D009195:Peroxidase; D010100:Oxygen; C067430:TCV 309